Clinical Trials Browser

Has results × Brain Neoplasms × Lomustine × Clear all

NCT02986178 2025-07-11

Lerapolturev in Recurrent Malignant Glioma

Phase 2 Completed

121 enrolled 15 charts

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT02765165 2021-07-23

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

26 enrolled 20 charts

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence

NCT02343406 2020-05-22

INTELLANCE-2

Phase 2 Completed

266 enrolled 23 charts

Brain Neoplasms, Glioblastoma

NCT01067469 2020-03-17

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Completed

83 enrolled 15 charts

Brain Neoplasms, Glioblastoma

NCT00031590 2019-04-25

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Phase 2 Terminated

30 enrolled 5 charts

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

NCT00761280 2014-11-14

SAPPHIRE

Phase 3 Terminated

27 enrolled 28 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT00504660 2012-01-11

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Phase 2 Completed

75 enrolled 8 charts

Brain Neoplasms, Glioblastoma